ArticleVeterinary medicine and science2026
Exploring the Antibacterial and Antibiofilm Properties of Lactic Acid Bacteria Isolated From Sucuk and Dairy Products.
Article in Veterinary medicine and science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundLactic acid bacteria (LAB) isolated from traditional artisanal products without starter cultures represent a valuable source of novel strains with high potential.
objectivesThis study aimed to investigate the antibacterial and antibiofilm effects, as well as antibiotic resistance, of LAB isolated from traditional artisanal dairy and meat products.
methodsLAB identification was performed using MALDI-TOF-MS and 16S rRNA gene sequencing. The antimicrobial and antibiofilm activity of LAB isolates was assessed against Staphylococcus aureus (ATCC 25923), Listeria monocytogenes (ATCC 13932), Escherichia coli (ATCC 29998) and Bacillus cereus (ATCC 11778).
resultsA total of 90 isolates were obtained from 45 samples, and 35 isolates confirmed as LAB were further characterized. Out of the 35 LAB isolates, 7 demonstrated selective inhibition zones against L. monocytogenes and B. cereus, while showing no inhibition against S. aureus and E. coli. All seven isolates were found to be susceptible to chloramphenicol and ampicillin, and intermediately susceptible to gentamicin. Moreover, 42.85% of the isolates were phenotypically resistant to trimethoprim-sulfamethoxazole and 57.14% to ciprofloxacin and oxacillin. Among the seven potent strains, six showed significant antibiofilm activity (85%-100%) against at least one of the pathogens tested. The six dual-action isolates were later identified by 16S rRNA gene sequencing as Pediococcus pentosaceus (I-3, I-21 and I-36) and Lactiplantibacillus plantarum (I-5, I-6 and I-34), with 100% similarity to the reference sequences.
conclusionsThese results highlight the potential of traditional artisanal strains as natural antimicrobials and antibiofilm agents, which are contributing to ongoing evaluations of protective cultures in the health, food and biotechnology fields.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.